“The researchers borrowed from the cancer biology field and used a drug to inhibit a specific chromatin remodeling protein known as Brd4. “The results were exciting. In cellular and animal models of Fragile X Syndrome, we saw a return to normal numbers of neuronal synapses and a decrease in behavioral symptoms,” Korb says.”
that’s awesome @twinklestars !!
I urge you to keep posting news!
Tangentially relevant to sz because they’re using a drug to impact a protien overexpressed in a genetic disease in the brain. Although this gene and this protien may not be relevant to sz, the concept may be useful for other genetic conditions.